Home LiteratureArticle Details
PMID: 16373498 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry.

Groszer M, Erickson R, Scripture-Adams DD, Dougherty JD, Le Belle J, Zack JA, Geschwind DH, Liu X, Kornblum HI, Wu H

Abstract

Previous studies have demonstrated that a small subpopulation of brain tumor cells share key characteristics with neural stem/progenitor cells in terms of phenotype and behavior. These findings suggest that brain tumors might contain "cancer stem cells" that are critical for tumor growth. However, the molecular pathways governing such stem cell-like behavior remain largely elusive. Our previous study suggests that the phosphatase and tensin homologue deleted on chromosome 10 (PTEN) tumor suppressor gene, one of the most frequently mutated genes in glioblastomas, restricts neural stem/progenitor cell proliferation in vivo. In the present study, we sought to determine the role of PTEN in long-term maintenance of stem cell-like properties, cell cycle entry and progression, and growth factor dependence and gene expression. Our results demonstrate an enhanced self-renewal capacity and G(0)-G(1) cell cycle entry and decreased growth factor dependency of Pten null neural/stem progenitor cells. Therefore, loss of PTEN leads to cell physiological changes, which collectively are sufficient to increase the pool of self-renewing neural stem cells and promote their escape from the homeostatic mechanisms of proliferation control.

MeSH Terms
Animals Cell Cycle/physiology Cell Differentiation/physiology Cell Proliferation Cerebral Cortex/cytology Fibroblast Growth Factor 2/metabolism Gene Deletion Mice Oligonucleotide Array Sequence Analysis PTEN Phosphohydrolase/genetics,metabolism Stem Cells/cytology,metabolism
Chemicals
Fibroblast Growth Factor 2 PTEN Phosphohydrolase
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Groszer Matthias
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Erickson Rebecca
Scripture-Adams Deirdre D
Dougherty Joseph D
Le Belle Janel
Zack Jerome A
Geschwind Daniel H
Liu Xin
Kornblum Harley I
Wu Hong
References (45)
45 references, click to expand
  1. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.
    Cell. 1999 Oct 29;99(3):323-34 PMID: 10555148
  2. Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon.
    Dev Biol. 1999 Apr 1;208(1):166-88 PMID: 10075850
  3. Detection of cell cycle subcompartments by flow cytometric estimation of DNA-RNA content in combination with dual-color immunofluorescence.
    Cytometry. 2000 Feb 1;39(2):108-16 PMID: 10679728
  4. Mammalian neural stem cells.
    Science. 2000 Feb 25;287(5457):1433-8 PMID: 10688783
  5. Genetic control of cell size.
    Curr Opin Genet Dev. 2000 Oct;10(5):529-35 PMID: 10980431
  6. A genetic analysis of neural progenitor differentiation.
    Neuron. 2001 Feb;29(2):325-39 PMID: 11239426
  7. Regulation of longevity and stress resistance by Sch9 in yeast.
    Science. 2001 Apr 13;292(5515):288-90 PMID: 11292860
  8. The translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell growth in Drosophila.
    Nat Cell Biol. 2001 Jun;3(6):596-601 PMID: 11389445
  9. Stem cells, cancer, and cancer stem cells.
    Nature. 2001 Nov 1;414(6859):105-11 PMID: 11689955
  10. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease.
    Nat Genet. 2001 Dec;29(4):396-403 PMID: 11726926
  11. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway.
    Proc Natl Acad Sci U S A. 1999 May 25;96(11):6199-204 PMID: 10339565
  12. Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo.
    Cancer Res. 2004 Nov 1;64(21):7773-9 PMID: 15520182
  13. Growth rate and cell size modulate the synthesis of, and requirement for, G1-phase cyclins at start.
    Mol Cell Biol. 2004 Dec;24(24):10802-13 PMID: 15572683
  14. Intrinsic differences distinguish transiently neurogenic progenitors from neural stem cells in the early postnatal brain.
    Dev Biol. 2005 Feb 1;278(1):71-85 PMID: 15649462
  15. p21 loss compromises the relative quiescence of forebrain stem cell proliferation leading to exhaustion of their proliferation capacity.
    Genes Dev. 2005 Mar 15;19(6):756-67 PMID: 15769947
  16. PTEN deletion in Bergmann glia leads to premature differentiation and affects laminar organization.
    Development. 2005 Jul;132(14):3281-91 PMID: 15944184
  17. Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation.
    J Cell Biol. 2005 Aug 1;170(3):413-27 PMID: 16061694
  18. Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease.
    Nat Genet. 2001 Dec;29(4):404-11 PMID: 11726927
  19. Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo.
    Science. 2001 Dec 7;294(5549):2186-9 PMID: 11691952
  20. Genetic and biologic progression in astrocytomas and their relation to angiogenic dysregulation.
    Adv Anat Pathol. 2002 Jan;9(1):24-36 PMID: 11756757
  21. PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum.
    Development. 2002 Jul;129(14):3513-22 PMID: 12091320
  22. Systematic identification of pathways that couple cell growth and division in yeast.
    Science. 2002 Jul 19;297(5580):395-400 PMID: 12089449
  23. Targeted molecular therapy of GBM.
    Brain Pathol. 2003 Jan;13(1):52-61 PMID: 12580545
  24. Genetic markers in glioblastoma: prognostic significance and future therapeutic implications.
    Adv Anat Pathol. 2003 Jul;10(4):212-7 PMID: 12826827
  25. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation.
    Nature. 2003 Oct 30;425(6961):962-7 PMID: 14574365
  26. Cancerous stem cells can arise from pediatric brain tumors.
    Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15178-83 PMID: 14645703
  27. PTENless means more.
    Dev Biol. 2004 Sep 15;273(2):175-84 PMID: 15328005
  28. Evidence for a size-sensing mechanism in animal cells.
    Nat Cell Biol. 2004 Sep;6(9):899-905 PMID: 15322555
  29. Cancer stem cells in nervous system tumors.
    Oncogene. 2004 Sep 20;23(43):7267-73 PMID: 15378086
  30. Akt-1 expression level regulates CNS precursors.
    J Neurosci. 2004 Sep 29;24(39):8531-41 PMID: 15456827
  31. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma.
    Cancer Res. 2004 Oct 1;64(19):7011-21 PMID: 15466194
  32. Cell cycle kinetics of expanding populations of neural stem and progenitor cells in vitro.
    Biotechnol Bioeng. 2004 Nov 5;88(3):332-47 PMID: 15486940
  33. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system.
    Science. 1992 Mar 27;255(5052):1707-10 PMID: 1553558
  34. Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells.
    Neuron. 1994 Nov;13(5):1071-82 PMID: 7946346
  35. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.
    Science. 1997 Mar 28;275(5308):1943-7 PMID: 9072974
  36. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.
    Nat Genet. 1997 Apr;15(4):356-62 PMID: 9090379
  37. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.
    Nat Genet. 1997 May;16(1):64-7 PMID: 9140396
  38. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease.
    Hum Mol Genet. 1997 Aug;6(8):1383-7 PMID: 9259288
  39. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase.
    Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9052-7 PMID: 9256433
  40. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
    J Biol Chem. 1998 May 29;273(22):13375-8 PMID: 9593664
  41. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.
    Cell. 1998 Oct 2;95(1):29-39 PMID: 9778245
  42. The lipid phosphatase activity of PTEN is critical for its tumor supressor function.
    Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13513-8 PMID: 9811831
  43. Cluster analysis and display of genome-wide expression patterns.
    Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8 PMID: 9843981
  44. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene.
    Cancer Res. 1998 Dec 15;58(24):5667-72 PMID: 9865719
  45. The hallmarks of cancer.
    Cell. 2000 Jan 7;100(1):57-70 PMID: 10647931
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2006-01-03
Epub
2005-00-22
Pages
111-6
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC1325011
Subset
IM
Grants
PHS HHS · 65756 · United States
NINDS NIH HHS · NS38439 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com